Study ID: ABS-AS-102
Study Title
- Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
Teva Identifier
- ABS-AS-102
ClinicalTrials.gov Identifier
- NCT01844401
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 4 Years to 11 Years
Trial Duration
- 04/01/2013 - 10/01/2013
Phase
- Phase 1
Study Type
Interventional
